July 30, 2016 1:43 PM ET


Company Overview of Plandaí Biotechnology, Inc.

Company Overview

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.

17 Hanover Square

London,  W1S 1BN

United Kingdom

250 Employees


44 91 7900 9829

Key Executives for Plandaí Biotechnology, Inc.

Co-Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary
Age: 73
Total Annual Compensation: $180.0K
Corporate Secretary and Director
Age: 31
Total Annual Compensation: $120.0K
Compensation as of Fiscal Year 2015.

Plandaí Biotechnology, Inc. Key Developments

Plandaí Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt

Plandaí Biotechnology, Inc. filed its 10-K on Jun 30, 2016 for the period ending Jun 30, 2015. In this report its auditor, Pritchett, Siler & Hardy, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Plandaí Biotechnology, Inc. - Special Call

Plandaí Biotechnology, Inc. - Special Call

Plandai Biotechnology, Inc. to Include Phytofare® Catechin-Propheroid® Formulation in Grain-Based Pellets

Plandaí Biotechnology, Inc. announced that it will be expanding the previously announced clinical trial involving poultry to also include a Phytofare® catechin-proPheroid® formulation in grain-based pellets. If successful, this new delivery method could open the door for introducing pH2™ catechins, rich in antioxidants and omega 3 and 6 fatty acids as a wellness food supplement, for various livestock animals, such as poultry and bovines, and pets, including hooved animals, dogs, cats and birds. In a previously announced clinical trial, Plandaí completed the initial study with pH2™ catechins formulated in water to determine the efficacy levels in slaughter chicken plasma. Based on these findings, the new investigations will determine the levels of pH2™ catechin absorption through formulation into animal feed. This new approach has the potential to a provide an efficient method of controlling and protecting the clinical dosage of pH2™ catechins to the animal's blood plasma. The first phase of the new 3-phase poultry investigation is scheduled to commence in the second half of June following Ethics committee approval. The collective studies are designed to clinically demonstrate that pH2™ catechins are protected and delivered to the animals' blood plasma with overall benefits relating to improved wellness, reduced mortality levels and the reduction of the commercial growing life-cycle of the slaughter chicken.

Similar Private Companies By Industry

Company Name Region
Abcodia Ltd. Europe
Abeterno Ltd. Europe
Abgentis Ltd. Europe
ADC Biotechnology Ltd Europe
Advanced Gel Technology Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Plandaí Biotechnology, Inc., please visit www.plandaibiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.